SCYX
USDSCYNEXIS Inc. Common Stock
$0.640-0.010 (-1.538%)
Real-time Price
Healthcare
Drug Manufacturers - Specialty & Generic
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.650
High
$0.650
Low
$0.620
Volume
0.34M
Company Fundamentals
Market Cap
27.0M
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
0.43M
Exchange
NGM
Currency
USD
52-Week Range
Low $0.62Current $0.640High $1.49
Related News
Analyst Upgrades
Guggenheim Maintains Buy on SCYNEXIS, Lowers Price Target to $3
Guggenheim analyst Vamil Divan maintains SCYNEXIS with a Buy and lowers the price target from $4 to $3.
View more
GlobeNewswire
SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study
SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive candidiasisScynexis will promptly wind-down and terminate the MARIO studyThe payment from
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.